Thor Medical ASA (OSL: TRMED)

Thor Medical ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-39.56	-26.56	-
Depreciation & Amortization	0.73	0.33	-
Stock-Based Compensation	2.9	2.1	-3.3
Other Operating Activities	16.83	17.03	-5.46
Change in Other Net Operating Assets	-33	-32.4	-97.98
Operating Cash Flow	-27.59	-64.09	-409.08
Capital Expenditures	-	-	-5.63
Cash Acquisitions	4.26	4.26	-
Other Investing Activities	1.92	2.02	3.16
Investing Cash Flow	6.18	6.28	-2.46
Long-Term Debt Repaid	-	-0.16	-5.52
Net Debt Issued (Repaid)	0.04	-0.16	-5.52
Issuance of Common Stock	0.45	0.15	250.81
Other Financing Activities	-0.32	-0.32	-17.16
Financing Cash Flow	0.17	-0.33	228.13
Foreign Exchange Rate Adjustments	0.6	1.2	4.43
Miscellaneous Cash Flow Adjustments	0	0	-
Net Cash Flow	-20.65	-56.95	-178.99
Free Cash Flow	-27.59	-64.09	-414.71
Free Cash Flow Per Share	-0.12	-0.37	-3.60
Cash Interest Paid	-	-	0.07
Cash Income Tax Paid	0.76	0.76	1.1
Levered Free Cash Flow	-	-34.91	-
Unlevered Free Cash Flow	-	-34.91	-
Change in Net Working Capital	-	32.87	-

Source: S&P Capital IQ. Standard template. Financial Sources.